Genius Sports Limited Ordinary Shares (NY:GENI)

6.195 +0.175 (+2.91%)

Delayed Quote Updated: 11:28 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Genius Sports Limited Ordinary Shares

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

16 17 Next >

Where Genius Sports Stands With Analysts ↗

June 05, 2023

Via Benzinga

Investing in Sports Betting Stocks: What You Need to Know

June 01, 2023

Sports betting has become a popular form of entertainment worldwide, with millions of people placing wagers on their favorite sports

Via Spotlight Growth

Topics Law Enforcement

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2023 ↗

May 25, 2023

Via Benzinga

Sports Bettings' Brightest Stars Honored At Benzinga's First Titans Summit ↗

May 24, 2023

On Wednesday, May 24, at 11 am ET, an electrifying current of excitement coursed through the sports and financial worlds.

Via Benzinga

Why Genius Sports Stock Skyrocketed Today ↗

May 09, 2023

The market is sniffing out a bargain here if the company can deliver on management's guidance.

Via The Motley Fool

Why Genius Sports Stock Is Shooting Higher ↗

May 09, 2023

Genius Sports Limited (NYSE: GENI) shares are trading higher Tuesday following upbeat first-quarter results and raised FY23 guidance.

Via Benzinga

Benzinga Names Genius Sports A 'Heavy Hitter' Award Recipient At Inaugural BZ Titans Sports Betting Event ↗

May 24, 2023

A leading fantasy sports and sports betting company has been honored with the Heavy Hitter award from Benzinga at its first-ever Titans Sports Betting conference. What’s A Heavy Hitter?

Via Benzinga

12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session ↗

May 09, 2023

Via Benzinga

Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 09, 2023

Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.

Via Benzinga

What 5 Analyst Ratings Have To Say About Genius Sports ↗

March 20, 2023

Via Benzinga

Genius Sports To Benefit From The Rising Tide Of Sports Betting, Says Analyst ↗

March 20, 2023

Via Benzinga

McKesson, ICU Medical, Novavax And Other Big Stocks Moving Higher On Tuesday ↗

May 09, 2023

U.S. stocks traded lower, with the Dow Jones dropping around 50 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

10 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session ↗

May 09, 2023

Via Benzinga

Genius Sports Reports First Quarter Results Ahead of Expectations and Raises Full-Year Revenue and Group Adj. EBITDA Guidance

May 09, 2023

From Genius Sports Limited

Via Business Wire

Artificial Intelligence Engine Predicts GENI Stock to Gain 2% by June 2 ↗

May 05, 2023

Watch our new video to find out how you can get 3,000 more predictions just like this

Via InvestorPlace

Genius Sports Announces Upcoming Conference Schedule

May 03, 2023

From Genius Sports Limited

Via Business Wire

Genius Sports to Announce First Quarter 2023 Results on May 9

April 28, 2023

From Genius Sports

Via Business Wire

NYSE: GENI Investor Alert: Investigation over Potential Wrongdoing at Genius Sports Limited ↗

April 26, 2023

San Diego, CA -- (SBWIRE) -- 04/26/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Genius Sports Limited.

Via SBWire

Genius Sports Announces Availability of its 2022 Annual Report on Form 20-F

April 05, 2023

From Genius Sports Limited

Via Business Wire

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

March 21, 2023

The iconic money manager with a penchant for aggressive growth is beating the market in 2023. She could be ready to party like it's 2020 again.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For March 20, 2023 ↗

March 20, 2023

Via Benzinga

Genius Sports Showcases Second Spectrum Technology in Visual Product Demonstration

March 15, 2023

From Genius Sports Limited

Via Business Wire

Genius Sports Analysts Highlight Betting Technology Revenue, Long-Term Media Opportunity, NBA Partnership, & More ↗

March 13, 2023

Needham analyst Bernie McTernan reiterates Genius Sports Ltd (NYSE: GENI)

Via Benzinga

Why JAKKS Pacific Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 10, 2023

Gainers Barnes & Noble Education, Inc. (NYSE: BNED) jumped 39% to $2.39 after the company posted better-than-expected quarterly sales.

Via Benzinga

12 Consumer Discretionary Stocks Moving In Friday's Intraday Session ↗

March 10, 2023

Via Benzinga

Genius Sports' Q4 Highlights: 25% Revenue Growth, FY23 Outlook Cut, Foreign Currency Impact & More ↗

March 10, 2023

Via Benzinga

Genius Sports Exceeds Group Revenue and Adj. EBITDA Outlook in 2022 and Reaffirms Expectations for over 150% Adj. EBITDA Growth in 2023

March 10, 2023

From Genius Sports Limited

Via Business Wire

Earnings Scheduled For March 10, 2023 ↗

March 10, 2023

Companies Reporting Before The Bell • CSI Compressco (NASDAQ:CCLP) is estimated to report earnings for its fourth quarter. • Longeveron (NASDAQ:LGVN) is expected to report earnings for its fourth...

Via Benzinga

General Electric, Build-A-Bear Workshop, Asana And Other Big Stocks Moving Higher On Thursday ↗

March 09, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 50 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

NBA and Genius Sports / Second Spectrum Expand Partnership to Deepen NBA League Pass Innovations With Enhanced Basketball Analytics and Develop New Next Gen Platform

March 09, 2023

From Genius Sports

Via Business Wire

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.